Open AccessAcquired thrombotic thrombocytopenic purpura following Pfizer COVID‐19 vaccination
Author(s) -
Alislambouli Mawaddah,
Veras Victoria Andy,
Matta Jyoti,
Yin Faye
Publication year - 2022
Publication title -
ejhaem
Language(s) - English
Resource type - Journals
ISSN - 2688-6146
DOI - 10.1002/jha2.342
Subject(s) - vaccination , thrombotic thrombocytopenic purpura , covid-19 , medicine , virology , thrombocytopenic purpura , immunology , platelet , disease , infectious disease (medical specialty) , outbreak
Acquired thrombotic thrombocytopenic purpura (aTTP) is a rare disease and has occasionally been described after vaccination, especially against viral agents. We present a case of a patient who presents with the classic pentad of TTP a few days after receiving the first dose of the mRNA Pfizer COVID‐19 vaccine. To our knowledge, this is the second report of a de novo TTP following mRNA Pfizer COVID‐19 vaccination.